Malignant pleural mesothelioma shows a promising response to treatment with the antibody drug pembrolizumab, which is used to treat other cancers.
Source: MedicalNewsToday.com
Mesothelioma shows promising response to existing immunotherapy drug
Published in Health News
More from Health NewsMore posts in Health News »
- Banishing burnout in 2021: how to make an exercise routine you’ll actually stick with
- Health Secretary Alex Azar resigning on Jan. 20
- Biden to deploy FEMA, National Guard to set up Covid vaccine clinics across the U.S.
- UnitedHealth launches employer virtual primary care service
- New Covid variant first found in UK could become dominant strain in U.S. by March, CDC says